Purchase Order 75N98026P01464
- Not listed
- The National Institute on Aging awarded a purchase order to Jackson Laboratory for $2,990,233.07 on September 1, 2026, to expand, quality-control, curate, biobank, and distribute up to 936 isogenic Alzheimer's disease and related dementias induced pluripotent stem cell lines under the iPSC Neurodegenerative Disease Initiative. Work is performed at Jackson Laboratory's facility in Bethesda, Maryland. The scope encompasses 486 female SNV lines and 450 additional iPSC lines across six genetic...
- This firm fixed-price purchase order was awarded by the National Institute on Aging (NIA), a civilian federal agency, to the nonprofit research institution Jackson Laboratory in Bar Harbor, Maine. The $1,530,320.00 contract is for the development and supply of induced pluripotent stem cell (iPSC) lines for the NIA's Induced Pluripotent Stem Cell Neurodegenerative Disease Initiative (INDI) project. The contract has no set-aside designation and is expected to be completed by July 31, 2026. Jackson...
- This is a $1,393,264.00 firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian agency, to Jackson Laboratory, a non-profit research organization located in Bar Harbor, Maine. The contract is for the provision of induced pluripotent stem cell (iPSC) lines for the NIA's Neurodegeneration Initiative project. The work will be performed in Bar Harbor, Maine and the contract has a period of performance through August 31, 2025. This contract is not set-aside....
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $205,953 firm fixed-price purchase order to the Jackson Laboratory, a non-profit biomedical research institution, to generate a collection of engineered isogenic Alzheimer's diseases and related dementias (ADRD)-mutation induced pluripotent stem cell (iPSC) lines. The work was originally posted as a Sources Sought notice to identify qualified vendors, with no set-aside...
- Jackson Laboratory has been awarded a $4.9 million firm fixed-price contract by the National Institutes of Health National Institute on Aging to deliver up to 414 isogenic induced pluripotent stem cell lines for the iPSC Neurodegeneration Initiative project. The three-year contract, running from September 2020 through September 2023, was awarded under a small business set-aside competitive solicitation seeking proposals to generate additional alleles to support the NIH Neurodegeneration...
- The National Institute on Aging awarded a $20,527.53 firm fixed-price purchase order to The Jackson Laboratory for laboratory and testing services, with performance in Bar Harbor, Maine, and an ultimate completion date of May 31, 2022. The award was made on August 23, 2021, with no set-aside designation applied. Jackson Laboratory, a nonprofit biomedical research institution, is a premier provider of genetically engineered mouse models, specialized rodent strains, and associated research...
- This is a $6,006,560.00 Firm Fixed Price definitive contract awarded by the National Institute on Aging, a civilian agency, to The Jackson Laboratory, a non-profit organization, for IPSC Engineering Services. The contract has an ultimate completion date of September 19, 2025. The Jackson Laboratory is a non-profit biomedical research institution that specializes in mammalian genetics and genomics, providing research animals, husbandry services, molecular biology products, and other scientific...
- <p>The National Human Genome Research Institute awarded a purchase order to The Jackson Laboratory valued at $361,950 on February 13, 2026, for induced pluripotent stem cell (iPSC) generation and beta cell differentiation. Performance occurs at the awardee's Bethesda, Maryland facility. The order is firm fixed price with an ultimate completion date of February 12, 2027. No set-aside category applies to this procurement.</p>
- <p>The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $21,675.98 firm fixed-price purchase order to the Jackson Laboratory, a nonprofit biomedical research institution specializing in mammalian genetics and genomics. The contract is for custom breeding services with a period of performance from August 12, 2019 to August 11, 2020. The work will be performed in Bar Harbor, Maine. This award does not have a set-aside designation.</p>
- Jackson Laboratory has been awarded a firm fixed price purchase order valued at twenty-two thousand one hundred six dollars and eighty-eight cents ($22,106.88) by the Department of Health and Human Services' National Institutes of Health National Institute on Aging. The contract is for the custom breeding of mice to support the agency's ongoing longitudinal aging study in mice. No set-aside designation was used for this award. Performance will take place at Jackson Laboratory's facility in Bar...
The National Institute on Aging awarded a purchase order to Jackson Laboratory on September 1, 2026, for validation and optimization of one-step tagging in human induced pluripotent stem cells, with a ceiling value of $3,353,116 and firm fixed price. The award is a sole-source procurement under FAR 6.302-1, made without competitive competition. Work is performed in Bar Harbor, Maine, and supports the iPSC Neurodegenerative Disease Initiative (iNDI) and the Center of Alzheimer's Disease and Related Dementias (CARD). The base period runs from September 1, 2026, through August 31, 2027, with one option year. Market research confirmed Jackson Laboratory as the only known source capable of meeting requirements within the required timeframe while maintaining scientific continuity with the existing NIA-funded engineering program since 2019. Jackson Laboratory's qualifications include demonstrated capability in large-scale human iPSC engineering including CRISPR/Cas9-mediated targeting, established biological resources, validated quality control pipelines, and prior successful performance on related efforts. The originating sole-source notice was posted on August 17, 2026, with a capability statement deadline of August 21, 2026.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Validation and Optimization of ONE-STEP Tagging in Human induced Pluripotent Stem Cells | NIH-NOI-PCA-NIA-01590 | Department of Health and Human Services National Institutes of Health Office of Logisitics and Acquisition Operations | Special Notice 1/1 | 8/17/26, 11:19 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7m | 8/26/26 |